Invention Application
- Patent Title: NOVEL HETEROCYCLIC COMPOUNDS AS IRAK4 INHIBITORS
-
Application No.: PCT/IB2018/059745Application Date: 2018-12-07
-
Publication No.: WO2019111218A1Publication Date: 2019-06-13
- Inventor: SHARMA, Rajiv , BAHEKAR, Rajesh , JADAV, Pradip , GOSWAMI, Amitgiri , CHOPADE, Rajendra
- Applicant: CADILA HEALTHCARE LIMITED
- Applicant Address: Zydus Tower, Satellite Cross Roads, Ahmedabad, Gujarat 380015 IN
- Assignee: CADILA HEALTHCARE LIMITED
- Current Assignee: CADILA HEALTHCARE LIMITED
- Current Assignee Address: Zydus Tower, Satellite Cross Roads, Ahmedabad, Gujarat 380015 IN
- Agency: MAHLA, Aaysu et al.
- Priority: IN201721044237 20171208
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/04 ; C07D471/10 ; C07D487/04 ; C07D487/08 ; C07D487/10 ; C07D498/04 ; C07D498/10 ; C07D519/00 ; A61P29/00 ; A61K31/4725
Abstract:
The present invention relates to novel compounds of the general formula (I) their tautomeric forms, their enantiomers, their diastereoisomers, their pharmaceutically accepted salts, or pro-drugs thereof, which are useful for the treatment or prevention of cancer and inflammatory diseases associated with Interleukin-1 Receptor Associated Kinase (IRAK), and more particularly compounds that modulate the function of IRAK4.
Information query
